Cis- and trans-regulation of Irf8 enhancers during dendritic cell development.

IF 2.1 4区 医学 Q2 HEMATOLOGY
Experimental hematology Pub Date : 2025-10-01 Epub Date: 2025-07-16 DOI:10.1016/j.exphem.2025.104858
Akira Nishiyama, Tomohiko Tamura
{"title":"Cis- and trans-regulation of Irf8 enhancers during dendritic cell development.","authors":"Akira Nishiyama, Tomohiko Tamura","doi":"10.1016/j.exphem.2025.104858","DOIUrl":null,"url":null,"abstract":"<p><p>Dendritic cells (DCs) are mononuclear phagocytes that play a crucial role in the immune system by mediating innate and adaptive immunity. DC differentiation requires the establishment of DC-specific gene expression regulated by lineage-specific transcription factors. Recent studies have reported a series of transcription factors essential for DC differentiation, as well as the regulatory circuit composed of these transcription factors. Among these transcription factors, interferon regulatory factor 8 (IRF8) is pivotal for the differentiation of type 1 classical DCs (cDC1s). IRF8 establishes the enhancer landscape at the progenitor stage and also regulates the higher-order chromatin structure of cDC1-specific genes. Furthermore, the cell fate within the myeloid lineages is determined in an IRF8 dose-dependent manner. The enhancers that govern Irf8 expression have been identified and extensively studied. Notably, Irf8 expression is regulated by a complex interplay among 3' enhancers, each of which has a differentiation stage-specific effect. In this review, we discuss recent advances in our understanding of the regulatory mechanisms of IRF8 expression underlying cDC1 development.</p>","PeriodicalId":12202,"journal":{"name":"Experimental hematology","volume":" ","pages":"104858"},"PeriodicalIF":2.1000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental hematology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.exphem.2025.104858","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/16 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Dendritic cells (DCs) are mononuclear phagocytes that play a crucial role in the immune system by mediating innate and adaptive immunity. DC differentiation requires the establishment of DC-specific gene expression regulated by lineage-specific transcription factors. Recent studies have reported a series of transcription factors essential for DC differentiation, as well as the regulatory circuit composed of these transcription factors. Among these transcription factors, interferon regulatory factor 8 (IRF8) is pivotal for the differentiation of type 1 classical DCs (cDC1s). IRF8 establishes the enhancer landscape at the progenitor stage and also regulates the higher-order chromatin structure of cDC1-specific genes. Furthermore, the cell fate within the myeloid lineages is determined in an IRF8 dose-dependent manner. The enhancers that govern Irf8 expression have been identified and extensively studied. Notably, Irf8 expression is regulated by a complex interplay among 3' enhancers, each of which has a differentiation stage-specific effect. In this review, we discuss recent advances in our understanding of the regulatory mechanisms of IRF8 expression underlying cDC1 development.

树突状细胞发育过程中Irf8增强子的顺式和反式调控。
树突状细胞(dc)是一种单核吞噬细胞,通过介导先天免疫和适应性免疫在免疫系统中起着至关重要的作用。DC分化需要建立由谱系特异性转录因子调控的DC特异性基因表达。近年来的研究报道了一系列DC分化所必需的转录因子,以及由这些转录因子组成的调控回路。在这些转录因子中,干扰素调节因子8 (IRF8)是1型经典dc (cDC1s)分化的关键。IRF8在祖细胞阶段建立增强子景观,并调节cdc1特异性基因的高阶染色质结构。此外,骨髓谱系内的细胞命运以IRF8剂量依赖的方式决定。调控Irf8表达的增强子已经被确定并广泛研究。值得注意的是,Irf8的表达受3'增强子之间复杂的相互作用调控,每个增强子都具有分化阶段特异性的作用。在这篇综述中,我们讨论了我们对IRF8表达调控cDC1发展机制的理解的最新进展。摘要:树突状细胞是一种单核吞噬细胞,通过介导先天免疫和适应性免疫在免疫系统中起着至关重要的作用。转录因子干扰素调节因子8 (IRF8)对1型经典dc (cDC1s)的发展至关重要。IRF8在cDC1发育过程中建立增强子景观并调节高阶染色质结构。髓系谱系内的细胞命运以IRF8剂量依赖的方式决定。Irf8的表达受irf83 '增强子之间复杂的相互作用调控,每种增强子都具有特定于分化阶段的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Experimental hematology
Experimental hematology 医学-血液学
CiteScore
5.30
自引率
0.00%
发文量
84
审稿时长
58 days
期刊介绍: Experimental Hematology publishes new findings, methodologies, reviews and perspectives in all areas of hematology and immune cell formation on a monthly basis that may include Special Issues on particular topics of current interest. The overall goal is to report new insights into how normal blood cells are produced, how their production is normally regulated, mechanisms that contribute to hematological diseases and new approaches to their treatment. Specific topics may include relevant developmental and aging processes, stem cell biology, analyses of intrinsic and extrinsic regulatory mechanisms, in vitro behavior of primary cells, clonal tracking, molecular and omics analyses, metabolism, epigenetics, bioengineering approaches, studies in model organisms, novel clinical observations, transplantation biology and new therapeutic avenues.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信